| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.40B | +9.0% |
| Cost of Revenue | $705.5M | +6.2% |
| Gross Profit | $1.69B | +10.2% |
| R&D Expense | $329.3M | -1.9% |
| SG&A Expense | $266.4M | -20.0% |
| Operating Income | $2.7M | +101.3% |
| Interest Expense | $63.4M | +76.2% |
| Pre-tax Income | -$47.2M | +69.9% |
| Income Tax | $11.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $242.8M | +9.3% |
| Accounts Receivable | $386.3M | +6.0% |
| Inventory | $1.2M | -16.7% |
| Current Assets | $871.1M | +2.6% |
| Total Assets | $1.78B | -8.5% |
| Current Liabilities | $748.8M | +18.4% |
| Long-term Debt | $1.35B | -13.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $483.3M | +20.9% |
| Capital Expenditures | $25.0M | +6.3% |
| Investing Cash Flow | -$109.4M | -20.9% |
| Financing Cash Flow | -$351.1M | +1.9% |
| Free Cash Flow | $458.3M | +21.8% |
| +31.8% |
| Net Income | -$58.3M | +64.7% |
| EPS (Basic) | -$0.63 | +63.8% |
| EPS (Diluted) | -$0.63 | +63.8% |
| Total Liabilities |
| $2.13B |
| -5.2% |
| Stockholders' Equity | -$550.9M | -9.6% |